Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 7, Pages 1802
Publisher
MDPI AG
Online
2020-07-06
DOI
10.3390/cancers12071802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mycolicibacterium brumae Is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
- (2020) Marc Bach-Griera et al. Vaccines
- Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report
- (2019) Satomi Tanaka et al. BMC INFECTIOUS DISEASES
- Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity
- (2019) Mohd Saqib et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Insights From the Genome Sequence of Mycobacterium paragordonae, a Potential Novel Live Vaccine for Preventing Mycobacterial Infections: The Putative Role of Type VII Secretion Systems for an Intracellular Lifestyle Within Free-Living Environmental Predators
- (2019) Byoung-Jun Kim et al. Frontiers in Microbiology
- Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
- (2019) Michele Tameris et al. Lancet Respiratory Medicine
- Anti-Cancer Effects of Synergistic Drug–Bacterium Combinations on Induced Breast Cancer in BALB/c Mice
- (2019) Menaga Subramaniam et al. Biomolecules
- Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model
- (2019) So-Young Lee et al. CANCER LETTERS
- Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen
- (2018) Takahiro USHIGUSA et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Mechanisms of BCG immunotherapy and its outlook for bladder cancer
- (2018) Caroline Pettenati et al. Nature Reviews Urology
- Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer
- (2018) Himani Garg et al. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY
- Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer
- (2018) Samuel Alvarez-Arguedas et al. Translational Research
- Antitumor effect of recombinant Mycobacterium�smegmatis expressing MAGEA3 and SSX2 fusion proteins
- (2018) Wen Jian et al. Experimental and Therapeutic Medicine
- Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma
- (2018) Jessica Da Gama Duarte et al. Frontiers in Immunology
- Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity
- (2018) Angus G. Dalgleish et al. Journal of Translational Medicine
- Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice
- (2018) Estela Noguera-Ortega et al. Scientific Reports
- Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology
- (2018) Hideyuki Masuda et al. MOLECULAR PHARMACEUTICS
- Immunomodulatory effects of heat-killed Mycobacterium obuense on human blood dendritic cells
- (2017) Samer Bazzi et al. Innate Immunity
- Anti-tumor immunity via the superoxide-eosinophil axis induced by a lipophilic component of Mycobacterium lipomannan
- (2017) Toshihiro Ito et al. INTERNATIONAL IMMUNOLOGY
- Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design
- (2017) Mohsen Karbalaei Zadeh Babaki et al. MICROBIAL PATHOGENESIS
- Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria
- (2017) Samer Bazzi et al. Frontiers in Immunology
- Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
- (2017) Ricardo D. Lardone et al. Frontiers in Immunology
- Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
- (2017) Junbao Yang et al. Frontiers in Oncology
- A temperature sensitive Mycobacterium paragordonae induces enhanced protective immune responses against mycobacterial infections in the mouse model
- (2017) Byoung-Jun Kim et al. Scientific Reports
- Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy
- (2016) Yoshiyuki Koyama et al. BIOTECHNOLOGY LETTERS
- Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
- (2016) Angus G Dalgleish et al. BRITISH JOURNAL OF CANCER
- γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria
- (2016) Estela Noguera-Ortega et al. JOURNAL OF UROLOGY
- Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
- (2016) Michal Lotem et al. Journal of Immunology Research
- Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell lines
- (2016) Menaga Subramaniam et al. Scientific Reports
- Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment
- (2016) Estela Noguera-Ortega et al. Scientific Reports
- Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKCα signaling: A potential candidate in melanoma cancer therapy
- (2015) Kuntal Halder et al. CANCER BIOLOGY & THERAPY
- Antitumor activity of mHSP65-TTL enhanced by administration of low dose cyclophosphamide in pancreatic cancer-bearing mice
- (2015) Wei Xuan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice
- (2015) Maolei Xu et al. JOURNAL OF IMMUNOTHERAPY
- Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells via a Fas-dependent pathway
- (2015) Qingshan Pei et al. PANCREATOLOGY
- Liposome-Encapsulated CpG Enhances Antitumor Activity Accompanying the Changing of Lymphocyte Populations in Tumor via Intratumoral Administration
- (2015) Dong Hyeok Kim et al. Nucleic Acid Therapeutics
- Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
- (2015) Manh-Cuong Vo et al. Oncotarget
- Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a “Danger Signal” to Block Immune Escape of Tumor Cells
- (2015) Yoshiyuki Koyama et al. Pharmaceutics
- Z-100, an Immunomodulatory Extract of Mycobacterium tuberculosis Strain Aoyama B, Prevents Spontaneous Lymphatic Metastasis of B16-BL6 Melanoma
- (2014) Takayuki Horii et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma
- (2014) Jianping Yuan et al. Journal of Hematology & Oncology
- Nontuberculous mycobacteria in respiratory samples from patients with pulmonary tuberculosis in the state of Rondonia, Brazil
- (2014) Cleoni Alves Mendes de Lima et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- MUC1 and maltose-binding protein recombinant fusion protein combined with Bacillus Calmette-Guerin induces MUC1-specific and nonspecific anti-tumor immunity in mice
- (2014) FANG FANG et al. Molecular Medicine Reports
- IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer
- (2014) Hilary Bilyard et al. Journal for ImmunoTherapy of Cancer
- A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo
- (2014) Daniel Fowler et al. Journal for ImmunoTherapy of Cancer
- A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer
- (2013) Chandresh Sharma et al. IMMUNOLOGIC RESEARCH
- Mycobacterium paragordonae sp. nov., a slowly growing, scotochromogenic species closely related to Mycobacterium gordonae
- (2013) B.-J. Kim et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Increased Numbers of Monocyte-Derived Dendritic Cells during Successful Tumor Immunotherapy with Immune-Activating Agents
- (2013) S. Kuhn et al. JOURNAL OF IMMUNOLOGY
- Toll-like receptors in urothelial cells—targets for cancer immunotherapy
- (2013) Hélène LaRue et al. Nature Reviews Urology
- A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma
- (2013) Masato Abei et al. Radiation Oncology
- ESAT-6-gpi DNA Vaccine Augmented the Specific Antitumour Efficacy Induced by the Tumour Vaccine B16F10-ESAT-6-gpi/IL-21 in a Mouse Model
- (2013) X. He et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Long-term survival and outcome of patients originally givenMycobacterium vaccaefor metastatic malignant melanoma
- (2013) Ferdinando CM Cananzi et al. Human Vaccines & Immunotherapeutics
- Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines
- (2012) Nina Gottschalk et al. BMC CANCER
- Mycobacterium phlei, a previously unreported cause of pacemaker infection: Thinking outside the box in cardiac device infections
- (2012) Showri Karnam et al. Cardiology Journal
- Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse
- (2012) Xiangfeng He et al. IMMUNOLOGIC RESEARCH
- A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in mice
- (2012) Youyou Yan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice
- (2012) Ming Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhancement of immunogenicity of murine lymphocytic leukemia cells by transfection with BCG heat shock protein 70 gene
- (2012) Xiao-Ling Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L
- (2012) Jian Gao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Connaught and Russian Strains Showed the Highest Direct Antitumor Effects of Different Bacillus Calmette-Guérin Substrains
- (2012) Silvia Secanella-Fandos et al. JOURNAL OF UROLOGY
- Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model
- (2012) Ankan Gupta et al. VACCINE
- Chemotherapeutically Induced Cutaneous Tuberculosis after BCG Injection in a Patient with Pelvic Osteosarcoma
- (2012) Giovanni Zoccali et al. Surgical Infections
- Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
- (2012) Stuart K. Calderwood et al. Frontiers in Immunology
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
- (2011) J. Stebbing et al. ANNALS OF ONCOLOGY
- Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
- (2011) Daniel W. Fowler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFNγ
- (2011) Srabanti Rakshit et al. INTERNATIONAL JOURNAL OF CANCER
- Misdiagnosis of Mycobacterium brumae Infection
- (2011) M. S. Jimenez et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice
- (2011) Faiz Ahmad et al. PLoS One
- Bacillus Calmette-Guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy
- (2010) Jae-Min Yuk et al. Autophagy
- Vaccination with B16 Tumor Cell Lysate Plus Recombinant Mycobacterium tuberculosis Hsp70 Induces Antimelanoma Effect in Mice
- (2010) He Li et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo
- (2010) Xue Jun Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synergistic antitumor effects of Escherichia coli maltose binding protein and Bacillus Calmette–Guerin in a mouse lung carcinoma model
- (2010) Qingyong Zhang et al. IMMUNOLOGY LETTERS
- Immunization with two recombinant Bacillus Calmette-Guérin vaccines that combine the expression of multiple tandem repeats of mucin-1 and colony stimulating-factor suppress breast tumor growth in mice
- (2010) Shifang Yuan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prolonged Survival of Allografts Induced by Mycobacterial Hsp70 Is Dependent on CD4+CD25+ Regulatory T Cells
- (2010) Thiago J. Borges et al. PLoS One
- Mifamurtide
- (2010) James E. Frampton PEDIATRIC DRUGS
- A Novel Bacillus Calmette-Guérin-based Breast Cancer Vaccine that Coexpresses Multiple Tandem Repeats of MUC1 and CD80 Breaks the Immune Tolerance and Inhibits MUC1-Positive Breast Cancer Growth
- (2009) Shifang Yuan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Growth inhibition of HeLa cell by internalization of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) Tokyo
- (2009) Akira Kitamura et al. Cancer Cell International
- A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth
- (2009) Tomoe Higuchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy of ovarian cancer with cell wall skeleton ofMycobacterium bovisBacillus Calmette-Guérin: Effect of lymphadenectomy
- (2009) Akira Hayashi et al. CANCER SCIENCE
- The fusion protein of HSP65 with tandem repeats of β-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma
- (2009) Hu Xiangbing et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors
- (2008) Masashi Murata CANCER SCIENCE
- Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma
- (2008) Lavakumar Karyampudi et al. CELLULAR IMMUNOLOGY
- Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer
- (2008) Andrew Bottomley et al. EUROPEAN JOURNAL OF CANCER
- Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung
- (2007) J.L. Stanford et al. EUROPEAN JOURNAL OF CANCER
- Allogeneic whole-cell vaccine: a phase I/II study in men with hormone-refractory prostate cancer
- (2004) J.D. Eaton et al. BJU INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started